Carbon Nanotube-Based Delivery Vectors for Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 5247
Special Issue Editor
Interests: nanomedicine; drug delivery; nanotoxicology; carbon-based nanomaterials; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a major public health problem, as it is the second leading cause of death globally. Although existing therapeutic modalities have shown great promise in cancer therapy, we are still far from the ideal cure that will not only improve patient life expectancy dramatically but also totally cure the body from its malignancy. While current therapies suffer from the issue of relapse after treatment, which could be due to drug resistance and poor drug uptake into the tumour, especially in the case of chemotherapeutics; cancer patients are still suffering from drastic side-effects post-treatment which are affecting their quality of life. In order to overcome these problems, the field of cancer drug delivery has evolved in recent years especially with the development of nano-sized drug delivery systems such as carbon nanotubes (CNTs). CNTs are graphene sheets rolled up into a tubular structure. Functionalised CNTs have shown an extraordinary and yet different cellular uptake fashion through what is known as the “Nanoneedle Hypothesis”, an energy-independent uptake mechanism. This meant that CNTs could improve the poor cellular uptake of chemotherapeutics as well as overcome drug resistance. Their unique cellular uptake mechanism could also be revolutionary in the delivery of therapeutic macromolecules, such as protein and nucleic acid, as they would avoid the endosome–lysosome compartment. In addition, their large surface area offers an enormous platform for the attachment of therapeutic and diagnostic molecules, and their unique thermal properties have shown great promise in hypothermia therapy.
Therefore, the use of CNTs in cancer therapy is a promising new strategy that can revolutionize cancer treatment. For this reason, we are proposing this Special Issue on “Carbon Nanotube-Based Delivery Vectors for Cancer Therapy”, which will highlight current advances in cancer drug delivery using carbon nanotubes and provide an overview of their potential in the delivery of cancer therapeutics ranging from small molecules to macromolecules but also their uniqueness in photothermal therapy. We invite articles on all aspects of CNT cancer therapy as briefly outlined in the Special Issue’s scope.
Dr. Hanene Ali-Boucetta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Carbon nanotubes for the delivery of small chemotherapeutics
- Carbon nanotubes for the delivery of macromolecules for cancer therapy (excluding gene therapy)
- Cancer gene therapy using carbon nanotubes
- The use of carbon nanotubes in hyperthermia treatment/photothermal therapy
- Cancer immunotherapy: What can carbon nanotubes offer?
- Cancer targeting using CNTs
- CNT potential in radiotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
